Insiders · Profile

Mahoney Stephen F.

President and CEO at Viridian Therapeutics, Inc.\DE · See Remarks at Dianthus Therapeutics, Inc. /DE/. Filing since 16 Sep 2021. CIK 0001741389

Company

Date

Role

Action

Amount

Of holding

27 Sep 2024

President and CEO

Bought

21,400

$499.26K

opened

16 Sep 2021

See Remarks

Sold, plan not stated

5,736

$38.60K

28.7%

2 decisions on file.